Daniela Piani-Meier

Predicting risk of secondary progression in multiple sclerosis: A nomogram

Ali Manouchehrinia, Feng Zhu, Daniela Piani-Meier et al. · Multiple Sclerosis Journal · 2018 · 78 citations

Public Health, Biostatistics, Neurology +15

A Physician-Completed Digital Tool for Evaluating Disease Progression (Multiple Sclerosis Progression Discussion Tool): Validation Study

Tjalf Ziemssen, Daniela Piani-Meier, Bryan Bennett et al. · Journal of Medical Internet Research · 2020 · 54 citations · Full text

Education, Neurology, Clinical Decision Support +16

Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years

Bruce Cree, Douglas L. Arnold, Robert J. Fox et al. · Multiple Sclerosis Journal · 2022 · 47 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +14

A mixed methods approach towards understanding key disease characteristics associated with the progression from RRMS to SPMS: Physicians’ and patients’ views

Tjalf Ziemssen, Chloe Tolley, Bryan Bennett et al. · Multiple Sclerosis and Related Disorders · 2019 · 44 citations · Full text

Nursing, Neurology, Neuroscience +16

Effect of siponimod on magnetic resonance imaging measures of neurodegeneration and myelination in secondary progressive multiple sclerosis: Gray matter atrophy and magnetization transfer ratio analyses from the EXPAND phase 3 trial

Douglas L. Arnold, Daniela Piani-Meier, Amit Bar‐Or et al. · Multiple Sclerosis Journal · 2022 · 35 citations · Full text

Medicine, Neurology, Neuroscience +17